Influence of different types of cyclodextrins on the racemization of scopolamine-N-butylbromide

被引：14

作者：

Bunke, A ^{[1
]}

Jira, T ^{[1
]}

Beyrich, T ^{[1
]}

机构：

[1] UNIV GREIFSWALD,DEPT PHARM,INST DRUG CONTROL,D-17487 GREIFSWALD,GERMANY

来源：

JOURNAL OF CHROMATOGRAPHY A | 1996年 / 728卷 / 1-2期

关键词：

racemization; mobile-phase composition; enantiomer separation; cyclodextrins; scopolamine-N-butylbromide; tropic acid;

D O I：

10.1016/0021-9673(95)01060-2

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

The influence of cyclodextrins (CDs) on the racemization and hydrolysis of scopolamine-N-butylbromide was determined kinetically. alpha-CD and gamma-CD enhance the racemization rate of the substance. beta-CD shows no effect and DM-beta-CD (dimethyl-beta-CD) causes inhibition of racemization. The hydrolysis of the substance was retarded by beta-, gamma- and DM-beta-CD. In the presence of alpha-CD no change in hydrolysis rate was observed.

引用

页码：441 / 445

页数：5

共 12 条

[1] ASO Y, 1990, CHEM PHARM BULL, V38, P180
[2] ASO Y, 1989, CHEM PHARM BULL, V37, P2786
[3] BEYRICH T, 1994, PHARMAZIE, V49, P34
[4] RACEMIZATION AND HYDROLYSIS OF TROPIC ACID ALKALOIDS IN THE PRESENCE OF CYCLODEXTRINS
BLASCHKE, G
LAMPARTER, E
SCHLUTER, J
[J]. CHIRALITY, 1993, 5 (02) : 78 - 83
[5] INFLUENCE OF CYCLODEXTRINS ON ESTER HYDROLYSIS
CHIN, TF
CHUNG, PH
LACH, JL
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (01) : 44 - &
[6] Cramer F., 1954, EINSCHLUSSVERBINDUNG
[7] Griffiths D. W., 1973, Adv. Catal, V23, P209
[8] RAPID AND COMPLETE CHIRAL CHROMATOGRAPHIC-SEPARATION OF RACEMIC QUATERNARY TROPANE ALKALOIDS - COMPLEMENTARY USE OF A CELLULOSE-BASED CHIRAL STATIONARY PHASE IN REVERSED-PHASE AND NORMAL-PHASE MODES - A MECHANISTIC STUDY
HAMPE, TRE
SCHLUTER, J
BRANDT, KH
NAGEL, J
LAMPARTER, E
BLASCHKE, G
[J]. JOURNAL OF CHROMATOGRAPHY, 1993, 634 (02): : 205 - 214
[9] RACEMIZATION OF CHLORTHALIDONE IN THE PRESENCE OF LIPOSOMES
LAMPARTER, E
BLASCHKE, G
SCHLUTER, J
[J]. CHIRALITY, 1993, 5 (05) : 370 - 374
[10] SCHNEIDER W., 1951, ARCH PHARM U BER DEUTSCH PHARM GES, V284, P306, DOI 10.1002/ardp.19512840514

← 1 2 →